Jan A. Nolta is a prominent American biomedical scientist and a leading researcher in the field of stem cell biology and regenerative medicine. She is widely recognized for her work at the University of California, Davis (UC Davis), where she serves as the Director of the UC Davis Stem Cell Program and the Institute for Regenerative Cures.
Nolta's research primarily focuses on the therapeutic potential of stem cells and gene therapy for a wide range of human diseases. Her work has significantly contributed to the understanding and application of various stem cell types, including mesenchymal stromal cells (MSCs) and induced pluripotent stem cells (iPSCs), for treating neurological disorders such as Huntington's disease, Alzheimer's disease, and Parkinson's disease, as well as metabolic disorders, cardiovascular conditions, and skeletal defects.
A key aspect of her career has been the translation of promising laboratory findings into clinical applications. She has been instrumental in moving stem cell therapies from basic research through preclinical development to human clinical trials, aiming to develop new treatments that utilize the regenerative and immunomodulatory capabilities of stem cells. Her contributions include pioneering methods for the isolation, expansion, and transplantation of specific stem cell populations, as well as exploring the use of genetically engineered stem cells as delivery vehicles for therapeutic genes.
Through her leadership at the Institute for Regenerative Cures, Nolta oversees a comprehensive research enterprise dedicated to advancing stem cell therapies from foundational science to clinical implementation, fostering interdisciplinary collaborations and partnerships.